TFS International has announced an agreement with the Pharma Intelligence division of Informa for their global research and development (R&D) platform – Citeline.
“At TFS we are already proud of the strategic and operational services that we provide our biotechnology and pharma clients.” said Dr Saleh. “This agreement with Citeline will take us to the next level and provide the strategy and operational team’s access to global, R&D intelligence platforms on a par with the largest CRO organizations.”
The importance of this Citeline and other technology investments to TFS was highlighted by Chief Executive Officer, János Filakovský, “We are very excited about our cooperation with Citeline. We will continue to invest in industry leading technologies, and in our people to provide innovative, data-driven productive solutions to our global customers.”